Advertisement

Glaxo to End Payments to Clinicians for Speaking Engagements — Physician’s First Watch

Medical News |
December 18, 2013

Glaxo to End Payments to Clinicians for Speaking Engagements

By Amy Orciari Herman

GlaxoSmithKline is set to begin phasing out payments to healthcare providers for speaking "on its behalf, about its products or disease areas, to audiences who can prescribe or influence prescribing," the company announced on Tuesday.

In addition, Glaxo will no longer pay clinicians to attend medical conferences; rather, it will finance provider education via "unsolicited, independent educational grant routes." These changes will be rolled out beginning in 2014, with completion by 2016.

Glaxo will also change how it pays its salespeople: sales targets will be abandoned by 2015, and personnel will be "rewarded for their technical knowledge, the quality of the service they deliver to support improved patient care and the overall performance of GSK's business."

The New York Times notes that the changes come "at a particularly sensitive time" for the company, which has been accused of funneling illegal payments to clinicians and government officials in China.

Reader Comments (2)

IBRAHIM SAYAD Physician, Mowasat hospital

A very respectable policy

IBRAHIM SAYAD Physician, Dermatology, Mowasat hospital

A very respectable attitude

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement